Bexarotene | Targretin® (topical) (Eisai Medical Research, Inc.) | Treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. | Drug Information Portal
MedlinePlus |
Denileukin diftitox | Ontak® (Eisai Medical Research, Inc.) | Treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of the IL-2 receptor. | Drug Information Portal
|
Romidepsin | Istodax (Gloucester Pharmaceuticals, Inc.) | Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy | Drug Information Portal
|